Seeking Alpha

Pfizer's (PFE -0.2%) Viagra patent has been ruled no longer valid by Canada's top court, backing...

Pfizer's (PFE -0.2%) Viagra patent has been ruled no longer valid by Canada's top court, backing an appeal by generic drug maker Teva Pharmaceutical (TEVA +0.1%) that claimed PFE hadn't provided sufficient details when it initially filed its patent registration.
Comments (1)
  • taplinger
    , contributor
    Comments (237) | Send Message
     
    Was it the current CEO that made the decision to withhold the active ingredient or was it someone in senior management? It would be nice to have accountability. This is the kind of thing that gives pharmaceuticals a bad name.
    9 Nov 2012, 12:47 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs